Estradiol in vivo induces changes in cardiomyocytes size in obese rats

Angiology

Volumn 66, Issue 1, 2015, Pages 25-35

  Obradovic, Milan ^a   Sudar, Emina ^a   Zafirovic, Sonja ^a   Stanimirovic, Julijana ^a   Labudovic Borovic, Milica ^b   Isenovic, Esma R ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cardiac hypertrophy; Estradiol; IR; Obesity

Indexed keywords

C REACTIVE PROTEIN; ESTRADIOL; GLUCOSE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; CHOLESTEROL; GLUCOSE BLOOD LEVEL; MAPK1 PROTEIN, RAT; MITOGEN ACTIVATED PROTEIN KINASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CELL SIZE; CHEMICAL PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; HEART MUSCLE CELL; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; MALE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; RAT; SINGLE DRUG DOSE; ANIMAL; BLOOD; CARDIOMEGALY; DISEASE MODEL; DRUG EFFECTS; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARDIOMEGALY; CELL SIZE; CHOLESTEROL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ESTRADIOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INJECTIONS, INTRAPERITONEAL; INSULIN; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MYOCYTES, CARDIAC; OBESITY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84927172355     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713514477     Document Type: Article

References (75)

1. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 2003;112(12):1785-1788.
2. Lehrke M, Lazar M.A. Inflamed about obesity. Nat Med. 2004; 10(2):126-127.
3. Iacobellis G, Ribaudo MC, Leto G, et al. Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obes Res. 2002;10(8):767-773.
4. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Di Mario U, Leonetti F. Adapted changes in left ventricular structure and function in severe uncomplicated obesity. Obes Res. 2004; 12(10):1616-1621.
5. Ouwens DM, Boer C, Fodor M, et al. Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats. Diabetologia. 2005;48(6):1229-1237.
6. Leopoldo AS, Sugizaki MM, Lima-Leopoldo AP, et al. Cardiac remodeling in a rat model of diet-induced obesity. Can J Cardiol. 2010;26(8):423-429.
7. Barrett-Connor E, Giardina EG, Gitt AK, Gudat U, Steinberg HO, Tschoepe D. Women and heart disease: the role of diabetes and hyperglycemia. Arch Intern Med. 2004;164(9):934-942.
8. Shi H, Clegg DJ. Sex differences in the regulation of body weight. Physiol Behav. 2009;97(2):199-204.
9. Knowlton AA, Lee AR. Estrogen and the cardiovascular system. Pharmacol Ther. 2012;135(1):54-70.
10. Murphy E. Estrogen signaling and cardiovascular disease. Circ Res. 2011;109(6):687-696.
11. Szalay L, Shimizu T, Suzuki T, et al. Estradiol improves cardiac and hepatic function after trauma-hemorrhage: role of enhanced heat shock protein expression. Am J Physiol Regul Integr Comp Physiol. 2006;290(3):R812-R818.
12. van Eickels M, Grohe C, Cleutjens JP, Janssen BJ, Wellens HJ, Doevendans PA. 17beta-estradiol attenuates the development of pressure-overload hypertrophy. Circulation. 2001; 104(12):1419-1423.
13. Gardner JD, Murray DB, Voloshenyuk TG, Brower GL, Bradley JM, Janicki JS. Estrogen attenuates chronic volume overload induced structural and functional remodeling in male rat hearts. Am J Physiol Heart Circ Physiol. 2010;298(2):H497-H504.
14. Barros RP, Gustafsson JA. Estrogen receptors and the metabolic network. Cell Metab. 2011;14(3):289-299.
15. Handgraaf S, Riant E, Fabre A, et al. Prevention of obesity and insulin resistance by estrogens requires ERalpha activation function-2 (ERalphaAF-2), whereas ERalphaAF-1 is dispensable. Diabetes. 2014;62(12):4098-4108.
16. Pedram A, Razandi M, Aitkenhead M, Hughes CC, Levin ER. Integration of the non-genomic and genomic actions of estrogen. membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem. 2002;277(52):50768-50775.
17. Sudar E, Velebit J, Gluvic Z, et al. Hypothetical mechanism of sodium pump regulation by estradiol under primary hypertension. J Theor Biol. 2008;251(4):584-592.
18. Isenovic ER, Meng Y, Jamali N, Milivojevic N, Sowers J.R. Ang II attenuates IGF-1-stimulated Na+, K(+)-ATPase activity via PI3K/Akt pathway in vascular smooth muscle cells. Int J Mol Med. 2004;13(6):915-922.
19. Ling S, Dai A, Williams MR, et al. The isoflavone metabolite cistetrahydrodaidzein inhibits ERK-1 activation and proliferation in human vascular smooth muscle cells. J Cardiovasc Pharmacol. 2004;43(5):622-628.
20. Camper-Kirby D, Welch S, Walker A, et al. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res. 2001;88(10):1020-1027.
21. Kehat I, Molkentin JD. Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy. Ann N Y Acad Sci. 2010;1188:96-102.
22. Hao L, Wang Y, Duan Y, Bu S. Effects of treadmill exercise training on liver fat accumulation and estrogen receptor alpha expression in intact and ovariectomized rats with or without estrogen replacement treatment. Eur J Appl Physiol. 2010;109(5):879-886.
23. Kumagai S, Holmang A, Bjorntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand. 1993;149(1):91-97.
24. Stubbins RE, Najjar K, Holcomb VB, Hong J, Nunez NP. Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance. Diabetes Obes Metab. 2012;14(1):58-66.
25. Wagner JD, Thomas MJ, Williams JK, Zhang L, Greaves KA, Cefalu WT. Insulin sensitivity and cardiovascular risk factors in ovariectomized monkeys with estradiol alone or combined with nomegestrol acetate. J Clin EndocrinolMetab. 1998;83(3):896-901.
26. Zhu L, Brown WC, Cai Q, et al. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathwayselective insulin resistance. Diabetes. 2013;62(2):424-434.
27. Koricanac G, Tepavcevic S, Zakula Z, Milosavljevic T, Stojiljkovic M, Isenovic ER. Interference between insulin and estradiol signaling pathways in the regulation of cardiac eNOS and Na(+)/K(+)-ATPase. Eur J Pharmacol. 2011;655(1-3):23-30.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-275.
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
30. Duncombe WG. The colorimetric micro-determination of nonesterified fatty acids in plasma. Clin Chim Acta. 1964;9:122-125.
31. Stewart JC. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem. 1980;104(1):10-14.
32. van Son JA, Smedts F, de Wilde PC, et al. Histological study of the internal mammary artery with emphasis on its suitability as a coronary artery bypass graft. Ann Thorac Surg. 1993;55(1): 106-113.
33. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259): 680-685.
34. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76(9): 4350-4354.
35. Burnette WN. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981;112(2):195-203.
36. Donaldson C, Eder S, Baker C, et al. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptordependent pathway that increases calcineurin degradation. Circ Res. 2009;104(2):265-275.
37. Murase T, Hattori T, Ohtake M, et al. Effects of estrogen on cardiovascular injury in ovariectomized female DahlS.Z-Lepr(fa)/ Lepr(fa) rats as a new animal model of metabolic syndrome. Hypertension. 2012;59(3):694-704.
38. Patten RD, Pourati I, AronovitzMJ, et al. 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res. 2004;95(7): 692-699.
39. Hale SL, Birnbaum Y, Kloner RA. Estradiol, administered acutely, protects ischemic myocardium in both female and male rabbits. J Cardiovasc Pharmacol Ther. 1997;2(1):47-52.
40. Thawornchaisit P, de Looze F, Reid CM, Seubsman SA, Sleigh A. Health-risk factors and the prevalence of hypertension: crosssectional findings from a national cohort of 87,143 Thai open university students. Glob J Health Sci. 2013;5(4):126-141.
41. Sites CK, Tischler MD, Blackman JA, et al. Effect of short-term hormone replacement therapy on left ventricular mass and contractile function. Fertil Steril. 1999;71(1):137-143.
42. van Eickels M, Patten RD, Aronovitz MJ, et al. 17-beta-estradiol increases cardiac remodeling and mortality in mice with myocardial infarction. J Am Coll Cardiol. 2003;41(11):2084-2092.
43. Gromadzka-Ostrowska J, Przepiorka M, Romanowicz K. Influence of dietary fatty acids composition, level of dietary fat and feeding period on some parameters of androgen metabolism in male rats. Reprod Biol. 2002;2(3):277-293.
44. Li Y, Yang J, Li S, et al. N-myc downstream-regulated gene 2, a novel estrogen-targeted gene, is involved in the regulation of Na+/K+-ATPase. J Biol Chem. 2011;286(37):32289-32299.
45. Obradovic M, Bjelogrlic P, Rizzo M, et al. Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases. J Endocrinol. 2013;218(3):R13-R23.
46. Barros RP, Machado UF, Warner M, Gustafsson JA. Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc Natl Acad Sci U S A. 2006;103(5):1605-1608.
47. Pedram A, Razandi M, O'Mahony F, Lubahn D, Levin ER. Estrogen receptor-beta prevents cardiac fibrosis. Mol Endocrinol. 2010;24(11):2152-2165.
48. Manrique C, Lastra G, Habibi J, Mugerfeld I, Garro M, Sowers J.R. Loss of estrogen receptor alpha signaling leads to insulin resistance and obesity in young and adult female mice. Cardiorenal Med. 2012;2(3):200-210.
49. Gorres BK, Bomhoff GL, Morris JK, Geiger PC. In vivo stimulation of oestrogen receptor alpha increases insulin-stimulated skeletal muscle glucose uptake. J Physiol. 2011;589(pt 8):2041-2054.
50. Riant E, Waget A, Cogo H, Arnal JF, Burcelin R, Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology. 2009;150(5): 2109-2117.
51. Bryzgalova G, Lundholm L, Portwood N, et al. Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am J Physiol Endocrinol Metab. 2008;295(4):E904-E912.
52. Koricanac G, Milosavljevic T, Stojiljkovic M, et al. Impact of estradiol on insulin signaling in the rat heart. Cell Biochem Funct. 2009;27(2):102-110.
53. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010;140(6):900-917.
54. Jelenik T, Roden M. How estrogens prevent from lipid-induced insulin resistance. Endocrinology. 2013;154(3):989-992.
55. Roden M. Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes. Int J Obes (Lond). 2005;29 suppl 2:S111-S115.
56. Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 2010;375(9733): 2267-2277.
57. Christoffersen C, Bollano E, Lindegaard ML, et al. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology. 2003;144(8):3483-3490.
58. Tian YQ, Li S S, Su XD, et al. Effects of pioglitazone on high-fatdiet- induced ventricular remodeling and dysfunction in rats. J Cardiovasc Pharmacol Ther. 2012;17(2):223-228.
59. Zib I, Jacob AN, Lingvay I, et al. Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes. J Investig Med. 2007;55(5):230-236.
60. Zhou YT, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000;97(4):1784-1789.
61. Hewitt KN, Pratis K, Jones ME, Simpson ER. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology. 2004;145(4):1842-1848.
62. Resanovic I, Rizzo M, Zafirovic S, et al. Anti-atherogenic effects of 17beta-estradiol. Horm Metab Res. 2013;45(10):701-708.
63. Musatov S, Chen W, Pfaff DW, et al. Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci U S A. 2007;104(7): 2501-2506.
64. Hsieh YC, Choudhry MA, Yu H P, et al. Inhibition of cardiac PGC-1alpha expression abolishes ERbeta agonist-mediated cardioprotection following trauma-hemorrhage. FASEB J. 2006;20(8): 1109-1117.
65. Koricanac G, Tepavcevic S, Romic S, et al. Estradiol enhances effects of fructose rich diet on cardiac fatty acid transporter CD36 and triglycerides accumulation. Eur J Pharmacol. 2012; 694(1-3):127-134.
66. Tepavcevic S, Koricanac G, Zakula Z, Milosavljevic T, Stojiljkovic M, Isenovic ER. Interaction between insulin and estradiol in regulation of cardiac glucose and free fatty acid transporters. Horm Metab Res. 2011;43(8):524-530.
67. Jones ME, Thorburn AW, Britt KL, et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A. 2000;97(23):12735-12740.
68. Bagatell CJ, Knopp RH, Rivier JE, Bremner WJ. Physiological levels of estradiol stimulate plasma high density lipoprotein2 cholesterol levels in normal men. J Clin Endocrinol Metab. 1994; 78(4):855-861.
69. Zheng H, Li Y, Dai W, Wei C, Sun K, Tong Y. Role of endogenous estrogen on the incidence of coronary heart disease in men. Angiology. 2012;63(8):591-596.
70. Liu D, Bachmann KA. An investigation of the relationship between estrogen, estrogen metabolites and blood cholesterol levels in ovariectomized rats. J Pharmacol Exp Ther. 1998;286(1): 561-568.
71. El-Nasr A, Diab F, Bahgat N, Ahmed M, Thabet S, El-Dakkak S. Metabolic effects of estrogen and / or insulin in ovariectomized experimentally diabetic rats. J Am Sci. 2011;7(2):432-444.
72. Wang M, Tsai BM, Reiger KM, Brown JW, Meldrum DR. 17-beta-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia. J Mol Cell Cardiol. 2006;40(2):205-212.
73. Cossette E, Cloutier I, Tardif K, DonPierre G, Tanguay JF. Estradiol inhibits vascular endothelial cells pro-inflammatory activation induced by C-reactive protein. Mol Cell Biochem. 2013; 373(1-2):137-147.
74. Wang CH, Li SH, Weisel RD, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation. 2003;107(13):1783-1790.
75. Bueno OF, De Windt LJ, Tymitz KM, et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 2000;19(23):6341-6350.